• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. No Shortage of Suitors for Genzyme

    Facing dwindling drug pipelines, plenty of big pharma firms may end up jumping into the bidding for Genzyme, according to Morningstar's Karen Andersen.

  2. How Will M&A Affect Pharma Balance Sheets?

    Even if a potential Sanofi/Genzyme deal foretells a wave of consolidation, investors shouldn't worry about big pharma credit quality, says Morningstar's Julie Stralow.

  3. Gen-Probe: New Tests Key to Increasing Revenue

    Gen-Probe's Michael Watts sees five potential new product launches as delivering top-line growth next year.

  4. Portability Provision Simplifies Couples' Estate Planning

    Estate-planning expert Deborah Jacobs details how spouses can take advantage of the 'portability' tax provision, which allows them to maximize both partners' estate tax exclusion, and how this strategy differs from trusts.

1
blog comments powered by Disqus
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.